Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT)

Dario Soldateschi, Sara Bravaccini, Brunilde Berti, Alessandra Brogi, Tiziana Benicchi, Claudia Soldatini, Laura Medri, Francesco Fabbri, Franca De Paola, Dino Amadori, Daniele Calistri

Research output: Contribution to journalArticle

Abstract

Telomerase activity plays an important role in the two complementary processes of cellular immortalization and senescence. This enzyme is active in almost all tumors, but also in inflammatory and many normal proliferating cells. Therefore, the main limits of molecular determinations, such as telomeric repeat amplification protocol assay is that they are not able to discriminate between the enzymatic activity of tumor and normal cells. The most appropriate technique for this would be immunohistochemical determination using monoclonal antibodies. Very few monoclonal antibodies (Mabs) directed against the human telomerase reverse transcriptase (hTERT) are commercially available and in the present study, we developed a new Mab directed against this protein (TERT-3 36-10) to investigate the possibility of detecting immunoreactivity to this Mab by immunohistochemical and flow cytometric approaches. Immunohistochemical determination showed a lack of reactivity to the Mab in highly differentiated striated muscle tissue, a variable reactivity in dysplastic cervical epithelial tissue and similar and widespread immunoreactivity in cell lines and clinical tumors. Furthermore, we demonstrated the ability of this Mab to inhibit enzyme activity in cell extract from MCR bladder tumor cell line.

Original languageEnglish
Pages (from-to)370-378
Number of pages9
JournalJournal of Biotechnology
Volume118
Issue number4
DOIs
Publication statusPublished - Sep 10 2005

Fingerprint

Monoclonal antibodies
Tumor Cell Line
Tumors
Monoclonal Antibodies
Striated Muscle
Cell Aging
Telomerase
Enzymes
Cell Extracts
Urinary Bladder Neoplasms
Neoplasms
Epithelium
Cells
Tissue
Muscles
Enzyme activity
Amplification
Muscle
Assays
Proteins

Keywords

  • Flow cytometry
  • Immunohistochemistry
  • Inhibition assay
  • Monoclonal antibody
  • Telomerase

ASJC Scopus subject areas

  • Biotechnology

Cite this

Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT). / Soldateschi, Dario; Bravaccini, Sara; Berti, Brunilde; Brogi, Alessandra; Benicchi, Tiziana; Soldatini, Claudia; Medri, Laura; Fabbri, Francesco; De Paola, Franca; Amadori, Dino; Calistri, Daniele.

In: Journal of Biotechnology, Vol. 118, No. 4, 10.09.2005, p. 370-378.

Research output: Contribution to journalArticle

Soldateschi, Dario ; Bravaccini, Sara ; Berti, Brunilde ; Brogi, Alessandra ; Benicchi, Tiziana ; Soldatini, Claudia ; Medri, Laura ; Fabbri, Francesco ; De Paola, Franca ; Amadori, Dino ; Calistri, Daniele. / Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT). In: Journal of Biotechnology. 2005 ; Vol. 118, No. 4. pp. 370-378.
@article{a76cab4405ae487b9986f6c58e0443cd,
title = "Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT)",
abstract = "Telomerase activity plays an important role in the two complementary processes of cellular immortalization and senescence. This enzyme is active in almost all tumors, but also in inflammatory and many normal proliferating cells. Therefore, the main limits of molecular determinations, such as telomeric repeat amplification protocol assay is that they are not able to discriminate between the enzymatic activity of tumor and normal cells. The most appropriate technique for this would be immunohistochemical determination using monoclonal antibodies. Very few monoclonal antibodies (Mabs) directed against the human telomerase reverse transcriptase (hTERT) are commercially available and in the present study, we developed a new Mab directed against this protein (TERT-3 36-10) to investigate the possibility of detecting immunoreactivity to this Mab by immunohistochemical and flow cytometric approaches. Immunohistochemical determination showed a lack of reactivity to the Mab in highly differentiated striated muscle tissue, a variable reactivity in dysplastic cervical epithelial tissue and similar and widespread immunoreactivity in cell lines and clinical tumors. Furthermore, we demonstrated the ability of this Mab to inhibit enzyme activity in cell extract from MCR bladder tumor cell line.",
keywords = "Flow cytometry, Immunohistochemistry, Inhibition assay, Monoclonal antibody, Telomerase",
author = "Dario Soldateschi and Sara Bravaccini and Brunilde Berti and Alessandra Brogi and Tiziana Benicchi and Claudia Soldatini and Laura Medri and Francesco Fabbri and {De Paola}, Franca and Dino Amadori and Daniele Calistri",
year = "2005",
month = "9",
day = "10",
doi = "10.1016/j.jbiotec.2005.05.019",
language = "English",
volume = "118",
pages = "370--378",
journal = "Journal of Biotechnology",
issn = "0168-1656",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT)

AU - Soldateschi, Dario

AU - Bravaccini, Sara

AU - Berti, Brunilde

AU - Brogi, Alessandra

AU - Benicchi, Tiziana

AU - Soldatini, Claudia

AU - Medri, Laura

AU - Fabbri, Francesco

AU - De Paola, Franca

AU - Amadori, Dino

AU - Calistri, Daniele

PY - 2005/9/10

Y1 - 2005/9/10

N2 - Telomerase activity plays an important role in the two complementary processes of cellular immortalization and senescence. This enzyme is active in almost all tumors, but also in inflammatory and many normal proliferating cells. Therefore, the main limits of molecular determinations, such as telomeric repeat amplification protocol assay is that they are not able to discriminate between the enzymatic activity of tumor and normal cells. The most appropriate technique for this would be immunohistochemical determination using monoclonal antibodies. Very few monoclonal antibodies (Mabs) directed against the human telomerase reverse transcriptase (hTERT) are commercially available and in the present study, we developed a new Mab directed against this protein (TERT-3 36-10) to investigate the possibility of detecting immunoreactivity to this Mab by immunohistochemical and flow cytometric approaches. Immunohistochemical determination showed a lack of reactivity to the Mab in highly differentiated striated muscle tissue, a variable reactivity in dysplastic cervical epithelial tissue and similar and widespread immunoreactivity in cell lines and clinical tumors. Furthermore, we demonstrated the ability of this Mab to inhibit enzyme activity in cell extract from MCR bladder tumor cell line.

AB - Telomerase activity plays an important role in the two complementary processes of cellular immortalization and senescence. This enzyme is active in almost all tumors, but also in inflammatory and many normal proliferating cells. Therefore, the main limits of molecular determinations, such as telomeric repeat amplification protocol assay is that they are not able to discriminate between the enzymatic activity of tumor and normal cells. The most appropriate technique for this would be immunohistochemical determination using monoclonal antibodies. Very few monoclonal antibodies (Mabs) directed against the human telomerase reverse transcriptase (hTERT) are commercially available and in the present study, we developed a new Mab directed against this protein (TERT-3 36-10) to investigate the possibility of detecting immunoreactivity to this Mab by immunohistochemical and flow cytometric approaches. Immunohistochemical determination showed a lack of reactivity to the Mab in highly differentiated striated muscle tissue, a variable reactivity in dysplastic cervical epithelial tissue and similar and widespread immunoreactivity in cell lines and clinical tumors. Furthermore, we demonstrated the ability of this Mab to inhibit enzyme activity in cell extract from MCR bladder tumor cell line.

KW - Flow cytometry

KW - Immunohistochemistry

KW - Inhibition assay

KW - Monoclonal antibody

KW - Telomerase

UR - http://www.scopus.com/inward/record.url?scp=23044482266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044482266&partnerID=8YFLogxK

U2 - 10.1016/j.jbiotec.2005.05.019

DO - 10.1016/j.jbiotec.2005.05.019

M3 - Article

C2 - 16046022

AN - SCOPUS:23044482266

VL - 118

SP - 370

EP - 378

JO - Journal of Biotechnology

JF - Journal of Biotechnology

SN - 0168-1656

IS - 4

ER -